CXCL12 and cancer: As curcumin exhibited an inhibitory effect on the CXCL12/CXCR4 axis and the NF-κB signaling pathway in MCF7 cells, it was demonstrated that curcumin has the potential to modulate breast cancer TME by repressing both ADMSCs and cancer cells.